Download Citation
Article Source:
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets
Lin GHY,
Chai V,
Lee V,
Dodge K,
Truong T,
et al.
(2017)
TTI-621 (SIRPαFc), a CD47-blocking cancer immunotherapeutic, triggers phagocytosis of lymphoma cells by multiple polarized macrophage subsets.
PLOS ONE 12(10): e0187262.
https://doi.org/10.1371/journal.pone.0187262